{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:08:16Z","timestamp":1791209296763,"version":"4.1.0"},"reference-count":105,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Council?of?Scientific and Industrial Research, India","award":["CSPS 24\/RDSF\/IICT\/IHP-2401; ULIP (MLP002621)"],"award-info":[{"award-number":["CSPS 24\/RDSF\/IICT\/IHP-2401; ULIP (MLP002621)"]}]},{"name":"Department of Science and Technology, Ministry of Science and Technology","award":["EMR\/2017\/001183"],"award-info":[{"award-number":["EMR\/2017\/001183"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dysregulated wnt\/\u03b2-catenin signaling cascades drive self-renewal, proliferation, differentiation, and therapeutic resistance in cancer stem cells (CSCs), thus contributing to their tumor aggression and poor clinical outcomes. Earlier, we demonstrated that a glucocorticoid receptor (GR)-targeted liposomal formulation carrying dexamethasone (Dex) and the wnt\/\u03b2-catenin inhibitor FH535 (D1XFH) selectively sensitizes colorectal cancer (CRC) cells and suppresses tumor growth. Herein, we investigate the immuno-therapeutic potential of D1XFH, especially within colorectal CSCs and against tumor recurrence. Our results reveal that D1XFH significantly downregulates CD133 and stemness-associated transcription factors Nanog, Sox2, and Oct4 in CSCs. D1XFH induces selective cytotoxicity by enhancing ROS generation, triggering apoptosis, reducing clonogenic potential, inhibiting cellular migration, and reversing multidrug resistance in CSCs. Co-administration of D1XFH-engineered CSCs and D1XFH into subcutaneous tumor-bearing mice resulted in pronounced tumor regression, accompanied by inhibition of wnt\/\u03b2-catenin signaling, reversal of EMT, and antitumorigenic immune responses, while improving long-term survival. Additionally, D1XFH treatments post-tumor resection resulted in near-zero tumor recurrence, while zero recurrence was observed even after tumor re-challenge. We observed 250 day long-term survivability with possible resurgence of immune-memory response within tumor-resected, D1XFH-treated mice. Collectively, dual targeting of GR and wnt\/\u03b2-catenin-driven CSC engineering and immunomodulation is a promising strategy for colorectal cancer therapy.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6c00889","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:02:38Z","timestamp":1789574558000},"page":"5124-5150","source":"Crossref","is-referenced-by-count":0,"title":["Glucocorticoid Receptor-Mediated Engineered Cancer Stem Cell-Led Therapy and Inhibition of Recurrence in Colorectal Cancer"],"prefix":"10.1021","volume":"23","author":[{"given":"Pritam","family":"Das","sequence":"first","affiliation":[{"name":"CSIR-Indian Institute of Chemical Technology , , ,","place":["Hyderabad, India, 500007"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tithi","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"CSIR-Indian Institute of Chemical Technology , , ,","place":["Hyderabad, India, 500007"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmitha","family":"Vangala","sequence":"additional","affiliation":[{"name":"CSIR-Indian Institute of Chemical Technology , , ,","place":["Hyderabad, India, 500007"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerthana","family":"Murthati","sequence":"additional","affiliation":[{"name":"CSIR-Indian Institute of Chemical Technology , , ,","place":["Hyderabad, India, 500007"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumyadeep","family":"Poddar","sequence":"additional","affiliation":[{"name":"CSIR-Indian Institute of Chemical Technology , , ,","place":["Hyderabad, India, 500007"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjaneyulu","family":"Eanti","sequence":"additional","affiliation":[{"name":"CSIR-Indian Institute of Chemical Technology , , ,","place":["Hyderabad, India, 500007"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2336-6294","authenticated-orcid":true,"given":"Rajkumar","family":"Banerjee","sequence":"additional","affiliation":[{"name":"CSIR-Indian Institute of Chemical Technology , , ,","place":["Hyderabad, India, 500007"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"1","key":"2026100509320664700_cit1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics","volume":"73","author":"Siegel","year":"2023","journal-title":"Ca-A Cancer J. Clin."},{"issue":"3","key":"2026100509320664700_cit2","doi-asserted-by":"publisher","first-page":"BSR20200265","DOI":"10.1042\/bsr20200265","article-title":"Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways","volume":"40","author":"Wan","year":"2020","journal-title":"Biosci. Rep."},{"issue":"1","key":"2026100509320664700_cit3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/ijms22010130","article-title":"Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements","volume":"22","author":"Malki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"2026100509320664700_cit4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.gastro.2019.08.059","article-title":"Pathways of colorectal carcinogenesis","volume":"158","author":"Nguyen","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"2026100509320664700_cit5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4240\/wjgs.v15.i4.495","article-title":"Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review","volume":"15","author":"Kumar","year":"2023","journal-title":"World J. Gastrointest. Surg."},{"issue":"21","key":"2026100509320664700_cit6","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.3390\/cancers14215205","article-title":"Role of immunotherapy in the treatment of cancer: a systematic review","volume":"14","author":"Ling","year":"2022","journal-title":"Cancers"},{"key":"2026100509320664700_cit7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jconrel.2023.09.014","article-title":"Nano-enabled colorectal cancer therapy","volume":"362","author":"Pan","year":"2023","journal-title":"J. Controlled Release"},{"issue":"3","key":"2026100509320664700_cit8","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cancers13030376","article-title":"Cancer stem cells\ue5f8key players in tumor relapse","volume":"13","author":"Marzagalli","year":"2021","journal-title":"Cancers"},{"issue":"1S","key":"2026100509320664700_cit9","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1097\/md.0000000000004765","article-title":"Cancer stem cell signaling pathways","volume":"95","author":"Matsui","year":"2016","journal-title":"Medicine"},{"issue":"1","key":"2026100509320664700_cit10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"2026100509320664700_cit11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.clcc.2015.02.001","article-title":"Development of small molecules targeting the Wnt signaling pathway in cancer stem cells for the treatment of colorectal cancer","volume":"14","author":"Song","year":"2015","journal-title":"Clin. Colorectal Cancer"},{"issue":"16","key":"2026100509320664700_cit12","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.7150\/jca.19273","article-title":"FH535 inhibits proliferation and motility of colon cancer cells by targeting Wnt\/\u03b2-catenin signaling pathway","volume":"8","author":"Chen","year":"2017","journal-title":"J. Cancer"},{"issue":"6","key":"2026100509320664700_cit13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099272","article-title":"Targeting the Wnt\/\u03b2-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535","volume":"9","author":"Gedaly","year":"2014","journal-title":"PLoS One"},{"issue":"30","key":"2026100509320664700_cit14","doi-asserted-by":"publisher","first-page":"47145","DOI":"10.18632\/oncotarget.9975","article-title":"FH535, a \u03b2-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"2026100509320664700_cit15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduction Targeted Ther."},{"issue":"3","key":"2026100509320664700_cit16","first-page":"39","article-title":"Small molecule inhibitors as emerging cancer therapeutics","volume":"1","author":"Lavanya","year":"2014","journal-title":"Integr. Cancer Sci. Ther."},{"issue":"22","key":"2026100509320664700_cit17","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/jnci\/93.22.1739","article-title":"Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer","volume":"93","author":"Nishimura","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"issue":"13","key":"2026100509320664700_cit18","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1101\/gad.9.13.1608","article-title":"Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation","volume":"9","author":"Cole","year":"1995","journal-title":"Genes Dev."},{"issue":"6","key":"2026100509320664700_cit19","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1128\/mcb.17.6.3181","article-title":"Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms","volume":"17","author":"Rogatsky","year":"1997","journal-title":"Mol. Cell. Biol."},{"issue":"2\u22125","key":"2026100509320664700_cit20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jsbmb.2004.12.017","article-title":"Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia","volume":"93","author":"Ploner","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"2026100509320664700_cit21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/mt.2009.4","article-title":"Selective cancer targeting via aberrant behavior of cancer cell-associated glucocorticoid receptor","volume":"17","author":"Mukherjee","year":"2009","journal-title":"Mol. Ther."},{"key":"2026100509320664700_cit22","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s13346-025-01952-3","article-title":"Glucocorticoid receptor-targeted liposomal delivery of wnt\/\u03b2-catenin pathway inhibitor selectively induces efficient colorectal tumor regression","volume":"16","author":"Das","year":"2025","journal-title":"Drug Delivery Transl. Res."},{"issue":"17","key":"2026100509320664700_cit23","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.3748\/wjg.v19.i17.2603","article-title":"CD133: a cancer stem cells marker, is used in colorectal cancers","volume":"19","author":"Ren","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"7123","key":"2026100509320664700_cit24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Ricci-Vitiani","year":"2007","journal-title":"Nature"},{"issue":"81","key":"2026100509320664700_cit25","doi-asserted-by":"publisher","first-page":"77841","DOI":"10.1039\/c6ra07256a","article-title":"Asymmetric cationic lipid based non-viral vectors for an efficient nucleic acid delivery","volume":"6","author":"Meka","year":"2016","journal-title":"RSC Adv."},{"key":"2026100509320664700_cit26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/s0091-679x(08)00014-9","article-title":"Isolation and culture of colon cancer stem cells","volume":"86","author":"Cammareri","year":"2008","journal-title":"Methods Cell Biol."},{"issue":"4","key":"2026100509320664700_cit27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10616-014-9806-0","article-title":"Isolation of colorectal cancer stem-like cells","volume":"68","author":"Dotse","year":"2016","journal-title":"Cytotechnology"},{"issue":"21","key":"2026100509320664700_cit28","doi-asserted-by":"publisher","first-page":"10350","DOI":"10.1039\/d3nr04806c","article-title":"Engineered nanomicelles targeting proliferation and angiogenesis inhibit tumour progression by impairing the synthesis of ceramide-1-phosphate","volume":"16","author":"Yadav","year":"2024","journal-title":"Nanoscale"},{"issue":"7123","key":"2026100509320664700_cit29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature05372","article-title":"A human colon cancer cell capable of initiating tumour growth in immunodeficient mice","volume":"445","author":"O\u2019Brien","year":"2007","journal-title":"Nature"},{"key":"2026100509320664700_cit30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ejmech.2015.11.033","article-title":"Cationic lipid-conjugated hydrocortisone as selective antitumor agent","volume":"108","author":"Rathore","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"2026100509320664700_cit31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3393\/ac.2015.31.3.84","article-title":"Expression of the cancer stem cell markers CD44 and CD133 in colorectal cancer: an immunohistochemical staining analysis","volume":"31","author":"Hong","year":"2015","journal-title":"Annals Coloproctol."},{"issue":"70","key":"2026100509320664700_cit32","doi-asserted-by":"publisher","first-page":"33403","DOI":"10.18632\/oncotarget.23607","article-title":"Cancer stem cells in progression of colorectal cancer","volume":"9","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"2026100509320664700_cit33","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/sj.bjc.6604664","article-title":"CD133 expression is an independent prognostic marker for low survival in colorectal cancer","volume":"99","author":"Horst","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"3","key":"2026100509320664700_cit34","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.asjsur.2016.12.002","article-title":"Expression of the stem cell marker CD133 is related to tumor development in colorectal carcinogenesis","volume":"41","author":"Kazama","year":"2018","journal-title":"Asian J. Surg."},{"issue":"2","key":"2026100509320664700_cit35","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40487-022-00205-4","article-title":"Expression and prognostic significance of stem cell marker CD133 in survival rate of patients with colon cancer","volume":"10","author":"Ehteram","year":"2022","journal-title":"Oncol. Ther."},{"issue":"3","key":"2026100509320664700_cit36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10517-024-06026-x","article-title":"A validation study of CD133 as a reliable marker for identification of colorectal cancer stem-like cells","volume":"176","author":"You","year":"2024","journal-title":"Bull. Exp. Biol. Med."},{"key":"2026100509320664700_cit37","doi-asserted-by":"publisher","first-page":"1725716","DOI":"10.3389\/fphar.2025.1725716","article-title":"Lentinan inhibits colorectal cancer stemness by binding CD133 and suppressing the CD133\/p85\/p-AKT signaling axis","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"6","key":"2026100509320664700_cit38","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/s1773-2247(11)50076-0","article-title":"Cellular uptake of liposomes monitored by confocal microscopy and flow cytometry","volume":"21","author":"Ducat","year":"2011","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"2026100509320664700_cit39","doi-asserted-by":"publisher","first-page":"101875","DOI":"10.1016\/j.cocis.2024.101875","article-title":"Liposomes: Bridging the gap from lab to pharmaceuticals","volume":"75","author":"Eugster","year":"2025","journal-title":"Curr. Opin. Colloid Interface Sci."},{"issue":"3","key":"2026100509320664700_cit40","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/molecules28031498","article-title":"A review of different types of liposomes and their advancements as a form of gene therapy treatment for breast cancer","volume":"28","author":"Tseu","year":"2023","journal-title":"Molecules"},{"issue":"7","key":"2026100509320664700_cit41","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1021\/acs.molpharmaceut.6b00230","article-title":"Glucocorticoid receptor-targeted liposomal codelivery of lipophilic drug and anti-Hsp90 gene: strategy to induce drug-sensitivity, EMT-reversal, and reduced malignancy in aggressive tumors","volume":"13","author":"Mondal","year":"2016","journal-title":"Mol. Pharmaceutics"},{"issue":"3","key":"2026100509320664700_cit42","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1021\/acs.molpharmaceut.5b00900","article-title":"Development of liposomal formulation for delivering anticancer drug to breast cancer stem-cell-like cells and its pharmacokinetics in an animal model","volume":"13","author":"Ahmad","year":"2016","journal-title":"Mol. Pharmaceutics"},{"issue":"4","key":"2026100509320664700_cit43","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1021\/acsabm.5c00002","article-title":"Glucocorticoid Receptor-Targeted Nanoliposome for STAT3 Inhibition-Led Myeloid-Derived Suppressor Cell Modulation and Efficient Colon Cancer Treatment","volume":"8","author":"Bhattacharyya","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"2026100509320664700_cit44","doi-asserted-by":"publisher","first-page":"107294","DOI":"10.1016\/j.bioorg.2024.107294","article-title":"Bis-arylidene oxindoles for colorectal cancer nanotherapy","volume":"146","author":"Bhattacharyya","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"12","key":"2026100509320664700_cit45","doi-asserted-by":"publisher","first-page":"6745","DOI":"10.1039\/c4nr00974f","article-title":"Cancer cell-selective promoter recognition accompanies antitumor effect by glucocorticoid receptor-targeted gold nanoparticle","volume":"6","author":"Sau","year":"2014","journal-title":"Nanoscale"},{"issue":"3","key":"2026100509320664700_cit46","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1021\/acs.molpharmaceut.0c01091","article-title":"Self-assembling derivative of hydrocortisone as glucocorticoid receptor-targeted nanotherapeutics for synergistic, combination therapy against colorectal tumor","volume":"18","author":"Sridharan","year":"2020","journal-title":"Mol. Pharmaceutics"},{"issue":"19","key":"2026100509320664700_cit47","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.2217\/nnm-2016-0224","article-title":"Glucocorticoid receptor-mediated delivery of nano gold\u2212withaferin conjugates for reversal of epithelial-to-mesenchymal transition and tumor regression","volume":"11","author":"Agarwalla","year":"2016","journal-title":"Nanomedicine"},{"issue":"2","key":"2026100509320664700_cit48","doi-asserted-by":"publisher","first-page":"024105","DOI":"10.1088\/1748-605x\/abdb08","article-title":"Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer","volume":"16","author":"Jinka","year":"2021","journal-title":"Biomed. Mater."},{"key":"2026100509320664700_cit49","doi-asserted-by":"publisher","first-page":"101953","DOI":"10.1016\/j.redox.2021.101953","article-title":"Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance","volume":"44","author":"Tuy","year":"2021","journal-title":"Redox Biol."},{"issue":"1","key":"2026100509320664700_cit50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3260001","article-title":"Caspases: the executioners of apoptosis","volume":"326","author":"Cohen","year":"1997","journal-title":"Biochem. J."},{"issue":"1","key":"2026100509320664700_cit51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jconrel.2008.05.005","article-title":"Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine","volume":"130","author":"Yan","year":"2008","journal-title":"J. Controlled Release"},{"issue":"11","key":"2026100509320664700_cit52","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1089\/ars.2012.4529","article-title":"Reactive oxygen species in cancer stem cells","volume":"16","author":"Shi","year":"2012","journal-title":"Antioxid. Redox Signaling"},{"issue":"1","key":"2026100509320664700_cit53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-i","article-title":"A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V","volume":"184","author":"Vermes","year":"1995","journal-title":"J. Immunol. Methods"},{"issue":"5","key":"2026100509320664700_cit54","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"issue":"3","key":"2026100509320664700_cit55","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/cells14030170","article-title":"Cellular systems for colorectal stem cancer cell research","volume":"14","author":"Grigoreva","year":"2025","journal-title":"Cells"},{"key":"2026100509320664700_cit56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-0716-3052-5_22","article-title":"Transwell in vitro cell migration and invasion assays","volume-title":"Cell Viability Assays: Methods and Protocols","author":"Justus","year":"2023"},{"issue":"23","key":"2026100509320664700_cit57","doi-asserted-by":"publisher","first-page":"37377","DOI":"10.18632\/oncotarget.16343","article-title":"NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway","volume":"8","author":"Jana","year":"2017","journal-title":"Oncotarget"},{"key":"2026100509320664700_cit58","doi-asserted-by":"publisher","first-page":"112846","DOI":"10.1016\/j.jphotobiol.2024.112846","article-title":"Glucocorticoid receptor mediated sensitization of colon cancer to photodynamic therapy induced cell death","volume":"251","author":"Chilakamarthi","year":"2024","journal-title":"J. Photochem. Photobiol., B"},{"issue":"9","key":"2026100509320664700_cit59","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.4252\/wjsc.v7.i9.1150","article-title":"Common stemness regulators of embryonic and cancer stem cells","volume":"7","author":"Hadjimichael","year":"2015","journal-title":"World J. Stem Cell."},{"issue":"4","key":"2026100509320664700_cit60","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"2","key":"2026100509320664700_cit61","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/jclinpath-2017-204739","article-title":"Cancer stem cells in colorectal cancer: a review","volume":"71","author":"Munro","year":"2018","journal-title":"J. Clin. Pathol."},{"issue":"2","key":"2026100509320664700_cit62","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000512218","article-title":"Epithelial-mesenchymal transition (EMT) as a therapeutic target","volume":"211","author":"Jonckheere","year":"2022","journal-title":"Cells Tissues Organs"},{"issue":"1","key":"2026100509320664700_cit63","doi-asserted-by":"publisher","first-page":"5416923","DOI":"10.1155\/2018\/5416923","article-title":"Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment","volume":"2018","author":"Phi","year":"2018","journal-title":"Stem Cells Int."},{"issue":"4","key":"2026100509320664700_cit64","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/cancers12040961","article-title":"Targeting aldehyde dehydrogenases to eliminate cancer stem cells in gynecologic malignancies","volume":"12","author":"Muralikrishnan","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"2026100509320664700_cit65","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1186\/s12885-018-4572-6","article-title":"ALDH1A inhibition sensitizes colon cancer cells to chemotherapy","volume":"18","author":"Kozovska","year":"2018","journal-title":"BMC Cancer"},{"issue":"6","key":"2026100509320664700_cit66","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.3892\/mmr.2015.3291","article-title":"Side population cells and drug resistance in breast cancer","volume":"11","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"2026100509320664700_cit67","first-page":"49","article-title":"Isolation of cancer stem cells by side population method","volume-title":"Cancer Stem Cells: Methods and Protocols","author":"Shimoda","year":"2017"},{"issue":"1","key":"2026100509320664700_cit68","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/moh.0000000000000621","article-title":"Structural organization of the bone marrow and its role in hematopoiesis","volume":"28","author":"Lucas","year":"2021","journal-title":"Curr. Opin. Hematol."},{"key":"2026100509320664700_cit69","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/cancers10020052","article-title":"The epithelial-to-mesenchymal transition in cancer","volume":"10","author":"Roche","year":"2018","journal-title":"Cancers"},{"issue":"17","key":"2026100509320664700_cit70","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.3390\/cancers13174455","article-title":"Ki-67 as a prognostic biomarker in invasive breast cancer","volume":"13","author":"Davey","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"2026100509320664700_cit71","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/imr.13319","article-title":"Cancer immunity by tissue-resident type 1 innate lymphoid cells and killer innate-like T cells","volume":"323","author":"Zhang","year":"2024","journal-title":"Immunol. Rev."},{"key":"2026100509320664700_cit72","doi-asserted-by":"publisher","first-page":"1476904","DOI":"10.3389\/fimmu.2024.1476904","article-title":"CD8+ T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: Key to the success of immunotherapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"2026100509320664700_cit73","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12935-021-02089-2","article-title":"New insights into M1\/M2 macrophages: key modulators in cancer progression","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"2026100509320664700_cit74","doi-asserted-by":"publisher","first-page":"116154","DOI":"10.1016\/j.bcp.2024.116154","article-title":"Wnt signaling: Modulating tumor-associated macrophages and related immunotherapeutic insights","volume":"223","author":"Yuan","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"2026100509320664700_cit75","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.trecan.2024.07.009","article-title":"CD4+ T cells in antitumor immunity","volume":"10","author":"Montauti","year":"2024","journal-title":"Trends Cancer"},{"issue":"9","key":"2026100509320664700_cit76","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","article-title":"The roles of CD8+ T cell subsets in antitumor immunity","volume":"30","author":"St Paul","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"8","key":"2026100509320664700_cit77","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxw025","article-title":"Roles of regulatory T cells in cancer immunity","volume":"28","author":"Takeuchi","year":"2016","journal-title":"Int. Immunol."},{"issue":"1","key":"2026100509320664700_cit78","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"issue":"16","key":"2026100509320664700_cit79","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1158\/0008-5472.can-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res."},{"key":"2026100509320664700_cit80","doi-asserted-by":"publisher","first-page":"116203","DOI":"10.1016\/j.biopha.2024.116203","article-title":"Tumor immunotherapy resistance: Revealing the mechanism of PD-1\/PD-L1-mediated tumor immune escape","volume":"171","author":"Cui","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"2026100509320664700_cit81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-67577-0_1","article-title":"Tumor immuno-environment in cancer progression and therapy","volume-title":"Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy","author":"Kalinski","year":"2017"},{"issue":"20","key":"2026100509320664700_cit82","doi-asserted-by":"publisher","first-page":"13226","DOI":"10.1021\/acsnano.4c02337","article-title":"Triune nanomodulator enables exhausted cytotoxic T lymphocyte rejuvenation for cancer epigenetic immunotherapy","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"issue":"3","key":"2026100509320664700_cit83","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/cancers13030373","article-title":"Modulation of CD4 T cell response according to tumor cytokine microenvironment","volume":"13","author":"Accogli","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"2026100509320664700_cit84","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1038\/s41598-019-40078-8","article-title":"Inflammatory cytokines and change of Th1\/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"2026100509320664700_cit85","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1038\/s41467-024-49059-6","article-title":"Glycolysis inhibition induces anti-tumor central memory CD8+ T cell differentiation upon combination with microwave ablation therapy","volume":"15","author":"Tang","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"2026100509320664700_cit86","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1186\/s12964-024-01990-3","article-title":"CD69+ CD103+ CD8+ tissue-resident memory T cells possess stronger anti-tumor activity and predict better prognosis in colorectal cancer","volume":"22","author":"Wu","year":"2024","journal-title":"Cell Commun. Signaling"},{"issue":"9","key":"2026100509320664700_cit87","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s00262-024-03709-2","article-title":"Tissue-resident memory CD103+ CD8+ T cells in colorectal cancer: its implication as a prognostic and predictive liver metastasis biomarker","volume":"73","author":"Liu","year":"2024","journal-title":"Cancer Immunol., Immunother."},{"issue":"1","key":"2026100509320664700_cit88","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41467-024-54791-0","article-title":"Remodelling of the immune landscape by IFN\u03b3 counteracts IFN\u03b3-dependent tumour escape in mouse tumour models","volume":"16","author":"Lau","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"2026100509320664700_cit89","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1089\/jir.2024.0259","article-title":"IFN-\u03b3 approaches in tumor suppression, its challenges, and future directions: a review of recent advances","volume":"45","author":"Ataherian","year":"2025","journal-title":"J. Interferon Cytokine Res."},{"key":"2026100509320664700_cit90","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/cmar.s411168","article-title":"Wnt\/\u03b2-catenin signaling pathway in the development and progression of colorectal cancer","volume":"15","author":"He","year":"2023","journal-title":"Cancer Manage. Res."},{"issue":"4","key":"2026100509320664700_cit91","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11888-011-0106-1","article-title":"CD133, stem cells, and cancer stem cells: myth or reality?","volume":"7","author":"Yu","year":"2011","journal-title":"Curr. Colorectal Cancer Rep."},{"issue":"1","key":"2026100509320664700_cit92","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12964-020-00627-5","article-title":"Drug resistance and Cancer stem cells","volume":"19","author":"Li","year":"2021","journal-title":"Cell Commun. Signaling"},{"key":"2026100509320664700_cit93","doi-asserted-by":"publisher","first-page":"1704868","DOI":"10.3389\/fimmu.2025.1704868","article-title":"Cancer stem cells in hepatocellular carcinoma: therapy resistance and emerging treatments","volume":"16","author":"Yadav","year":"2025","journal-title":"Front. Immunol."},{"key":"2026100509320664700_cit94","doi-asserted-by":"publisher","first-page":"115112","DOI":"10.1016\/j.taap.2020.115112","article-title":"Targeting lung cancer stem cells using combination of Tel and Docetaxel liposomes in 3D cultures and tumor xenografts","volume":"401","author":"Arthur","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2026100509320664700_cit95","doi-asserted-by":"publisher","first-page":"101687","DOI":"10.1016\/j.jddst.2020.101687","article-title":"Peptide-conjugated liposomes for targeted miR-34a delivery to suppress breast cancer and cancer stem-like population","volume":"57","author":"Vakhshiteh","year":"2020","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"1","key":"2026100509320664700_cit96","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s12951-025-03538-0","article-title":"Targeting YTHDF2 with pH-responsive siRNA nanoparticles suppresses MYC m6A modification and restores antitumor immunity in hepatocellular carcinoma","volume":"23","author":"Guo","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"5","key":"2026100509320664700_cit97","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00432-024-05777-4","article-title":"The role of tumor-associated macrophages in tumor immune evasion","volume":"150","author":"Huang","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"14","key":"2026100509320664700_cit98","doi-asserted-by":"publisher","DOI":"10.1172\/jci180080","article-title":"Spatial and functional targeting of intratumoral Tregs reverses CD8+ T cell exhaustion and promotes cancer immunotherapy","volume":"134","author":"Zhou","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"1","key":"2026100509320664700_cit99","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s12967-022-03807-8","article-title":"Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer","volume":"20","author":"Chen","year":"2022","journal-title":"J. Transl. Med."},{"issue":"5","key":"2026100509320664700_cit100","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.7150\/thno.80091","article-title":"Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy","volume":"13","author":"Yin","year":"2023","journal-title":"Theranostics"},{"issue":"1","key":"2026100509320664700_cit101","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","article-title":"Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment","volume":"5","author":"Steggerda","year":"2017","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"2026100509320664700_cit102","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/cells13110964","article-title":"Tumor-infiltrating T cells in skin basal cell carcinomas and squamous cell carcinomas: Global Th1 preponderance with Th17 enrichment\ue5f8A cross-sectional study","volume":"13","author":"Cunha","year":"2024","journal-title":"Cells"},{"issue":"3","key":"2026100509320664700_cit103","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/cancers17030382","article-title":"Deciphering the role of cancer stem cells: Drivers of tumor evolution, therapeutic resistance, and precision medicine strategies","volume":"17","author":"El-Tanani","year":"2025","journal-title":"Cancers"},{"key":"2026100509320664700_cit104","doi-asserted-by":"publisher","first-page":"102106","DOI":"10.1016\/j.nantod.2023.102106","article-title":"Biomimetic fusion liposomes boosting antitumor immunity and promote memory T cell differentiation to inhibit postoperative recurrence of breast cancer","volume":"54","author":"Ning","year":"2024","journal-title":"Nano Today"},{"issue":"3","key":"2026100509320664700_cit105","doi-asserted-by":"publisher","first-page":"100800","DOI":"10.1016\/j.ajps.2023.100800","article-title":"Implantation of hydrogel-liposome nanoplatform inhibits glioblastoma relapse by inducing ferroptosis","volume":"18","author":"Wang","year":"2023","journal-title":"Asian J. Pharm. Sci."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6c00889","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/5124\/68534505\/mp6c00889.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/5124\/68534505\/mp6c00889.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:49:35Z","timestamp":1791208175000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/10\/5124\/5431455\/Glucocorticoid-Receptor-Mediated-Engineered-Cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":105,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,16]]},"published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00889","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}